Comparative effectiveness of simultaneous administration of mifepristone and misoprostol versus interval regimen of mifepristone followed by misoprostol 12 hours apart in second trimester medical abortion
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20182367Keywords:
Abortion, Induction abortion interval, Mifepristone and misoprostolAbstract
Background: In second trimester abortion, medical methods are preferred. Prostaglandins are the most widely used. Amongst them, misoprostol is the most commonly used. Thus, the study was conducted to delineate the effectiveness of simultaneous administration of mifepristone and misoprostol versus interval regimen mifepristone followed by misoprostol 12 hours apart in second trimester medical abortion.
Methods: It was a prospective, single centered, comparative study conducted on 50 patients in Department of Obstetrics and Gynaecology, GMC, Amritsar coming for second trimester abortion, either elective or emergency, with gestational age between 12-20 weeks. Initially, 53 patients were enrolled in the study, 3 patients dropped out at different stages of study. Finally, 50 patients were enrolled and divided into two groups of 25 patients each by 1:1 randomization. In Group-A, mifepristone 200 mg orally along with misoprostol 600µg vaginally were given simultaneously, followed by 400 µg vaginal misoprostol every 4 hours for a maximum of five doses in 24 hours. Group-B initially received mifepristone 200 mg per oral followed by 12 hours later misoprostol 400µg vaginally and then 400µg vaginal misoprostol every 4 hours for a maximum of five doses in 24 hours. Primary outcome measure was effectiveness of regimen in complete abortion, which was confirmed on pelvic ultrasound 1-week after the last dose. Secondary outcome measure was to compare the induction abortion interval (IAI), dose of misoprostol required and adverse drug reaction (ADR) among both the regimens. P-value <0.05 was taken as statistically significant.
Results: Mean age in Group-A was 25.68±3.79 years while in Group-B was 23.40±2.73 years. Both the regimens had success rate of 76% for complete abortion. However, IAI in Group-A was 5.9±4.47 hours whereas in Group-B was 9.6±5.07 hours, which was statistically significant (p= 0.009). A statistically significant difference was also observed in the mean dose of misoprostol between two groups that is, 1000±200µg and 1425±437.41µg respectively (p=0.01). Gestational age was related to IAI from 13 to 17.6 weeks in both groups (p=0.01) while no significant relation was seen between them in more than 17.6 weeks of gestation (p=0.63).
Conclusions: Simultaneous administration of mifepristone and misoprostol showed better results than interval regimen in term of significant lesser induction abortion interval, lower dosages of misoprostol required with comparable success rates.
Metrics
References
Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ and Spong CY. Chapter-1.Overview of Obstetrics. In: Cunningham, FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ and Spong CY, Eds. Williams Obstetrics, 23rd Edition. New York: McGraw-Hill.2010;143.
Gemzell-Danielsson K, Lalitkumar S. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management. Reprod Health Matters. 2008;16(31 Suppl):162-72.
Dass A, Mukhopadahyay P, Dhawan S. Termination of mid-trimester pregnancies by intra-amniotic injection of hypertonic saline. J Obstet Gynaecol India. 1975;25(3):323-30.
Weinberg PC, Shepard MK. Intraamniotic Urea for Induction of Mid-Trimester Abortion Obstet Gynecol. 1973;41(3):451-4.
Royal College of Obstetricians and Gynecologists. The care of women requesting induced abortion. Evidence-based Clinical Guideline Number 7. London: RCOG; 2011. Available at https://www.rcog.org.uk/globalassets/documents/guidelines/abortion_guideline_summary.pdf
Pike JE. Total synthesis of Prostaglandins. Fortschr Chem Org Naturst.1970;28:313-42.
Lalitkumar S, Bygdeman M, Gemzell-Danielsson K. Mid-trimester induced abortion: a review. Hum Reprod Update. 2007;13(1):37-52.
Sarkar NN. Mifepristone: bioavailability, pharmacokinetics and use-effectiveness. Eur J Obstet Gynecol Reprod Biol. 2002;101(2):113-20.
Ngoc NT, Shochet T, Raghavan S, Blum J, Nga NT, Mint NT et al. Mifepristone and misoprostol compared with misoprostol alone for second trimester abortion: a randomized controlled trial. Obstet Gynecol. 2011;118:601-8.
Nilas L, Glavind-Kristensen M, Vejborg T, Knudsen UB. One or two day mifepristone-misoprostol interval for second trimester abortion. Acta Obstet Gynecol Scand. 2007;86(9):1117-21.
Chai J, Tang OS, Hong QQ, Chen QF, Cheng LN, Ng E et al. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion. Hum Reprod. 2009;24(2):320-4.
Creinin MD, Schreiber CA, Bednarek P, Lintu H, Wagner MS, Meyn LA. Medical Abortion at the Same Time (MAST) Study Trial Group. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol. 2007;109(4):885-94.
Li YT, Hsieh JC, Hou GQ, Chen TH, Chu YC, Lin TC et al. Simultaneous use of mifepristone and misoprostol for early pregnancy termination.Taiwan J Obstet Gynecol. 2011;50(1):11-4.
Nagaria T, Sirmor N. Misoprostol vs mifepristone and misoprostol in second trimester termination of pregnancy. J Obstet Gynaecol India. 2011;61(6):659-62.
Patel U, Chauhan K, Singhi S, Kanani M. Second trimester abortion- mifepristone and misoprostol or misoprostol alone? Int J Reprod Contracept Obstet Gynecol. 2013;2:315-9.
Mentula M, Suhonen S, Heikinheimo O. One- and two-day dosing intervals between mifepristone and misoprostol in second trimester medical termination of pregnancy-a randomized trial. Hum Reprod. 2011;26(10):2690-7.
Downloads
Published
How to Cite
Issue
Section
